Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel by Yaki Saciuk, Jennifer Kertes, Micha Mandel, Beatriz Hemo, Naama Shamir Stein, Anat Ekka Zohar :: SSRN

Findings: mRNA BNT162b2 was found effective for the total population group for infection, hospitalization and mortality, with adjusted VE of 93·0% (CI:92·6-93·4%), 93·4% (CI:91·9-94·7%) and 91·1% (CI:86·5-94·1%) respectively. VE for infection was lower for participants aged 75 and over, and for those with hypertension, diabetes and obesity. Interpretation:This study strengthens the evidence that the Pfizer-BioNTech vaccination is effective in preventing infection, hospitalization and mortality. Source: Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel by Yaki Saciuk, Jennifer Kertes, Micha Mandel, Beatriz Hemo, Naama Shamir Stein, Anat Ekka Zohar :: SSRN